Sitazit-DM 10mg/500mg/100mg Tablet ER

Description

Sitazit-DM 10mg/500mg/100mg Tablet ER is a triple combination antidiabetic medicine formulated for the effective management of type 2 diabetes mellitus. It contains:

• Dapagliflozin (10mg): An SGLT2 inhibitor that lowers blood sugar by eliminating excess glucose through urine.

• Metformin (500mg): A biguanide that reduces glucose production in the liver and improves insulin sensitivity.

• Sitagliptin (100mg): A DPP-4 inhibitor that increases incretin hormone levels, boosting insulin release and reducing blood sugar after meals.

Together, they provide comprehensive blood sugar control, support weight management, and help reduce the risk of long-term diabetes complications.

Uses of Sitazit-DM Tablet ER

• Management of type 2 diabetes mellitus

• Improves fasting and postprandial blood glucose levels

• Offers benefits in weight reduction and blood pressure control

• Helps reduce risks of cardiovascular and kidney complications in diabetic patients

How to Use

• Take the tablet once daily (extended-release) or as prescribed by your doctor.

• Swallow whole with water; do not crush or chew.

• Can be taken with meals to reduce stomach discomfort.

• Follow a diabetic diet, exercise, and regular blood sugar monitoring for best results.

Side Effects

Common:

• Increased urination

• Nausea, stomach upset, or diarrhea (due to metformin)

• Headache

• Cold-like symptoms (nasopharyngitis)

Less common but serious:

• Lactic acidosis (rare, linked to metformin)

• Pancreatitis (severe abdominal pain)

• Dehydration or low blood pressure

• Genital or urinary tract infections

Precautions & Warnings

• Prescription Required – take only under medical guidance.

• Not suitable for type 1 diabetes or diabetic ketoacidosis.

• Use with caution in patients with kidney, liver, or heart disease.

• Ensure adequate hydration to prevent dehydration.

• Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.

• Regular monitoring of kidney function, liver enzymes, and blood sugar is recommended.

Conclusion

Sitazit-DM 10mg/500mg/100mg Tablet ER (Dapagliflozin + Metformin + Sitagliptin) is an advanced triple therapy for type 2 diabetes that works through multiple pathways to control blood sugar, support weight management, and lower risks of complications. When used with a balanced diet, exercise, and medical supervision, it offers effective and long-term diabetes management.